6:58 PM ET
Form 4
Insider Buying
Inhibrx Biosciences CEO Mark Lappe Buys $832K of Stock
Mark Lappe, CEO, bought 9,840 shares of Inhibrx Biosciences, Inc. at $84.07 to $85.00 a share (average $84.54) in 4 transactions, worth $832K in total on Oct 14, 2026. Shares held after the trade: 169,900 (+1.5%).
- Value
- $832K
- Shares
- 9,840
- Average price
- $84.54
- Role
- CEO
- Holding change
- +1.5%
- Trade date
- Oct 14, 2026